PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy (2015)
- Authors:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- DOI: 10.1038/modpathol.2014.85
- Subjects: NEOPLASIAS PROSTÁTICAS (GENÉTICA); PRÓSTATA (CIRURGIA); BIÓPSIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Modern Pathology
- ISSN: 0893-3952
- Volume/Número/Paginação/Ano: v. 28, n. 1, p. 128-137, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: unspecified-oa
-
ABNT
LOTAN, Tamara L et al. PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy. Modern Pathology, v. 28, n. 1, p. 128-137, 2015Tradução . . Disponível em: https://doi.org/10.1038/modpathol.2014.85. Acesso em: 28 dez. 2025. -
APA
Lotan, T. L., Carvalho, F. L. F., Peskoe, S. B., Hicks, J. L., Good, J., Fedor, H. L., et al. (2015). PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy. Modern Pathology, 28( 1), 128-137. doi:10.1038/modpathol.2014.85 -
NLM
Lotan TL, Carvalho FLF, Peskoe SB, Hicks JL, Good J, Fedor HL, Humphreys E, Han M, Platz EA, Squire JA, Marzo AMD, Berman DM. PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy [Internet]. Modern Pathology. 2015 ; 28( 1): 128-137.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1038/modpathol.2014.85 -
Vancouver
Lotan TL, Carvalho FLF, Peskoe SB, Hicks JL, Good J, Fedor HL, Humphreys E, Han M, Platz EA, Squire JA, Marzo AMD, Berman DM. PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy [Internet]. Modern Pathology. 2015 ; 28( 1): 128-137.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1038/modpathol.2014.85 - Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Extracellular vesicles: evolving factors in stem cell biology
- The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
Informações sobre o DOI: 10.1038/modpathol.2014.85 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
